BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1338280)

  • 1. Beta-adrenergic influences on doxorubicin-sensitive or -resistant P388 leukemia cells.
    D'Amico C; Crescimanno M; Armata MG; Leonardi V; Palazzoadriano M; D'Alessandro N
    Anticancer Res; 1992; 12(6B):2253-6. PubMed ID: 1338280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the efficacy of a phenothiazine and a bisquinaldinium calmodulin antagonist against multidrug-resistant P388 cell lines.
    Hait WN; Pierson NR
    Cancer Res; 1990 Feb; 50(4):1165-9. PubMed ID: 2297765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a bromoacetylated derivative of pindolol as a high affinity, irreversible beta adrenergic antagonist in cultured cells.
    Jasper JR; Motulsky HJ; Insel PA
    J Pharmacol Exp Ther; 1988 Mar; 244(3):820-4. PubMed ID: 2908047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid hormone differentially regulates development of beta-adrenergic receptors, adenylate cyclase and ornithine decarboxylase in rat heart and kidney.
    Pracyk JB; Slotkin TA
    J Dev Physiol; 1991 Oct; 16(4):251-61. PubMed ID: 1667405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Number and functionality of beta-adrenergic receptors in the mouse lymphocytic P388 leukemia as a doxorubicin-sensitive and -resistant variant.
    D'Amico C; Crescimanno M; Armata MG; Leonardi V; Palazzoadriano M; D'Alessandro N
    Pharmacol Res; 1992 Sep; 26 Suppl 2():168-9. PubMed ID: 1357644
    [No Abstract]   [Full Text] [Related]  

  • 6. Potentiation of pirarubicin cytotoxicity by dipyridamole in doxorubicin-resistant mouse P388 leukemia cells.
    Furusawa S; Fujimura T; Kawauchi H; Sasaki K; Takayanagi Y
    Res Commun Chem Pathol Pharmacol; 1991 Mar; 71(3):321-36. PubMed ID: 2047575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-Adrenergic receptors and adenylate cyclase activity in murine lymphoid cell lines.
    Staehelin M; Müller P; Portenier M; Harris AW
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(1):55-64. PubMed ID: 2984265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxygen radical detoxification enzymes in doxorubicin-sensitive and -resistant P388 murine leukemia cells.
    Ramu A; Cohen L; Glaubiger D
    Cancer Res; 1984 May; 44(5):1976-80. PubMed ID: 6324993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-adrenergic receptors and myogenesis.
    Schonberg M; Bilezikian JP; Apfelbaum M; Benn RC
    J Cyclic Nucleotide Res; 1978 Feb; 4(1):55-69. PubMed ID: 205563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptors for beta-adrenergic agonists in cultured chick ventricular cells. Relationship between agonist binding and physiologic effect.
    Marsh JD; Smith TW
    Mol Pharmacol; 1985 Jan; 27(1):10-8. PubMed ID: 2981398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct mechanisms of forskolin-stimulated cyclic AMP accumulation and forskolin-potentiated hormone responses in C6-2B cells.
    Barovsky K; Pedone C; Brooker G
    Mol Pharmacol; 1984 Mar; 25(2):256-60. PubMed ID: 6321948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Goldenberg GJ; Wang H; Blair GW
    Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered adrenergic response and specificity of the receptors in rat ascites hepatoma AH130.
    Sanae F; Miyamoto K; Koshiura R
    Cancer Res; 1989 Nov; 49(22):6242-6. PubMed ID: 2553251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ca2+ inhibition of beta-adrenergic receptor- and forskolin-stimulated cAMP accumulation in C6-2B rat glioma cells is independent of protein kinase C.
    Debernardi MA; Munshi R; Brooker G
    Mol Pharmacol; 1993 Mar; 43(3):451-8. PubMed ID: 8383803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophoretic mobility studies on doxorubicin-resistant and -sensitive murine P388 leukemic cells.
    Nair S; Horton A; Leif RC; Krishan A
    Cytometry; 1988 May; 9(3):232-7. PubMed ID: 3163971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine splenocyte migration inhibition assay I. Detection of differential responses to murine leukemia P388 and its adriamycin-resistant subline P388/ADR.
    Nori M; Gothoskar BP
    Neoplasma; 1983; 30(3):287-93. PubMed ID: 6223231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of beta adrenergic receptor binding characteristics and coupling to adenylate cyclase in rat pulmonary artery versus aorta.
    Shaul PW; Muntz KH; Buja LM
    J Pharmacol Exp Ther; 1990 Jan; 252(1):86-92. PubMed ID: 2153813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistance of murine leukemia cells characterization and correlation with cytochrome P-450 dependent activities, cytosolic calcium and cell cycle state.
    Pfeil D; Bergmann J; Fichtner I; Stein U; Hentschel M; Rothe I; Goan SR
    Anticancer Res; 1994; 14(2A):571-6. PubMed ID: 7912495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased phorbol ester receptor and protein kinase C in P388 murine leukemic cells resistant to etoposide.
    Ido M; Sato K; Sakurai M; Inagaki M; Saitoh M; Watanabe M; Hidaka H
    Cancer Res; 1987 Jul; 47(13):3460-3. PubMed ID: 3581082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of full and partial agonists with beta-adrenergic receptors on intact L6 muscle cells.
    Pittman RN; Molinoff PB
    Mol Pharmacol; 1983 Nov; 24(3):398-408. PubMed ID: 6138704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.